Connect with us

Australia

Twenty Seven in trading halt with capital raising announcement pending

Twenty Seven Co Ltd (ASX:TSC) has an announcement pending in regard to a proposed capital raising and has been granted a trading halt by the ASX.

The trading halt will remain in place until the beginning of normal ASX trade on Thursday, 6 February 2020, or when an announcement is released to the market, whichever occurs earliest.

Re-assays confirm up to 14 g/t gold at Rover[hhmc]
TSC recently revealed further high-grade shallow gold up to 14 g/t from the final batch of selected 1-metre re-assays from Creasy 1 within the Rover Project in WA.

The insight from the final gold re-assays enabled TSCs geology team to clearly identify two priority shallow high-grade gold targets around Creasy 1 to test-drill once the next campaign starts.

Next steps[hhmc]
Exploration at the Rover Project is being Read More – Source

[contf]
[contfnew]

Proactiveinvestors
[contfnewc]
[contfnewc]

Twenty Seven Co Ltd (ASX:TSC) has an announcement pending in regard to a proposed capital raising and has been granted a trading halt by the ASX.

The trading halt will remain in place until the beginning of normal ASX trade on Thursday, 6 February 2020, or when an announcement is released to the market, whichever occurs earliest.

Re-assays confirm up to 14 g/t gold at Rover


TSC recently revealed further high-grade shallow gold up to 14 g/t from the final batch of selected 1-metre re-assays from Creasy 1 within the Rover Project in WA.

The insight from the final gold re-assays enabled TSCs geology team to clearly identify two priority shallow high-grade gold targets around Creasy 1 to test-drill once the next campaign starts.

Next steps


Exploration at the Rover Project is being Read More – Source

Continue Reading

Australia

Medlab Clinical completes NRGBiotic™ depression trial

Medlab Clinical Ltd (ASX:MDC) shares rose almost 16% upon completing the intervention stage of a trial for depression using its NRGBiotic product.

The trial closed at 120 patients and aimed to follow-on from previous trials investigating the use of NRGBiotic versus placebo as an adjuvant (used with) to a selective serotonin reuptake inhibitor (SSRI) and or serotonin-norepinephrine reuptake inhibitor (SNRI) which are common anti-depressant medications for people diagnosed with depression.

Shares in the company closed at 22 cents, up from 13.5 cents on March 27.

Medlab chief executive officer Dr Sean Hall said: “Personally, in light of the COVID impact, I am very pleased we have been able to fulfil our research duties with minimal interference to participants, and whilst the intervention stage is completed, the trial cohort will for the next three months focus on testing outcomes and an independent analysis of those results.”

Medlab has indicated that completion of this trial, whilst..

Medlab Clinical Ltd (ASX:MDC) shares rose almost 16% upon completing the intervention stage of a trial for depression using its NRGBiotic™ product.

The trial closed at 120 patients and aimed to follow-on from previous trials investigating the use of NRGBiotic™ versus placebo as an adjuvant (used with) to a selective serotonin reuptake inhibitor (SSRI) and or serotonin-norepinephrine reuptake inhibitor (SNRI) which are common anti-depressant medications for people diagnosed with depression.

Shares in the company closed at 22 cents, up from 13.5 cents on March 27.

Medlab chief executive officer Dr Sean Hall said: “Personally, in light of the COVID impact, I am very pleased we have been able to fulfil our research duties with minimal interference to participants, and whilst the intervention stage is completed, the trial cohort will for the next three months focus on testing outcomes and an independent analysis of those results.”

Medlab has indicated that completion of this trial, whilst retaining its statistical relevance, is a key driver for the business moving forward in managing the companys exposure to COVID and any potential economic impact.

“Milestone achievement”


Medlab director of medical research Professor Luis Vitetta said: “The completion of a randomised placebo-controlled study with patients diagnosed with major depression unresponsive to standard pharmaceutical medications is a significant milestone achievement for Medlabs research group.”

Vitetta said: “We look forward to the independent analysis of the data that will provide important links between the gut bacteria cohort, blood metabolites and mood; and the level of treatment efficacy achieved for depression with a Medlab patented formulation.”

Pathology and an independent review is expected in three months.

Depression trRead More – Source

Continue Reading

Australia

Animoca Brands and Atari virtual platform sees surge in demand due to COVID-19 lockdowns

Animoca Brands Corporation Limiteds blockchain gaming platform The Sandbox recently partnered with Atari and has just launched its third LAND presale.

The third presale launched and sold out ~50% in around five minutes. Further, 95% of the ATARI neighbourhood sold out in less than three hours.

Animoca chairman Yat Siu said that demand is being driven by recent lockdowns and isolation periods which are a result of COVID-19.

The Sandbox[hhmc]
Animocas The Sandbox is a virtual world where players can build, own and monetise their own voxel gaming experiences on the Ethereum blockchain.

The Sandbox has partnered with Atari, one of the worlds most iconic gaming brands, to create 3D voxel versions of beloved Atari game properties including Asteroids, Centipede, Pong and RollerCoaster Tycoon.

[embedded content]

Animoca and Ataris vision is to offer a deeply immersive metaverse in which virtual worlds and games will be created collaboratively and without a central authority.

Under th..

Animoca Brands Corporation Limiteds blockchain gaming platform The Sandbox recently partnered with Atari and has just launched its third LAND presale.

The third presale launched and sold out ~50% in around five minutes. Further, 95% of the ATARI neighbourhood sold out in less than three hours.

Animoca chairman Yat Siu said that demand is being driven by recent lockdowns and isolation periods which are a result of COVID-19.

The Sandbox


Animocas The Sandbox is a virtual world where players can build, own and monetise their own voxel gaming experiences on the Ethereum blockchain.

The Sandbox has partnered with Atari, one of the worlds most iconic gaming brands, to create 3D voxel versions of beloved Atari game properties including Asteroids, Centipede, Pong and RollerCoaster Tycoon.

Animoca and Ataris vision is to offer a deeply immersive metaverse in which virtual worlds and games will be created collaboratively and without a central authority.

Under the terms of the agreement, Atari will receive large digital spaces, known as ESTATEs, iRead More – Source

Continue Reading

Australia

Ironbark Zinc major shareholder continues to build indirect holdings with on-market purchases

Ironbark Zinc Limited (ASX:IBG) major shareholder and non-executive director Danny Segman continues to support the companys base metals strategy with on-market share purchases.

On March 27 and 31 an entity in which Segman has a beneficial interest, Toronga Pty Ltd, acquired more than 1.875 million shares.

This took the number of shares held in the indirect interest to almost 82.417 million while another of Segmans indirect interests, Dulyne Pty Ltd, holds 67 million IBG shares.

Series of transactions[hhmc]
It is the latest in a series of on-market transactions by interests associated with Segman this year.

On March 24, 25 and 26 Toronga Pty Ltd acquired 3.54 million shares valued at more than $18,400 while on March 12 seven million shares were acquired worth more than $49,000.

Jewel in the crown[hhmc]
The company is confident that its Citronen Zinc-Lead Project in Greenland offers a rare scale and grade combination with a long mining life in a unique jurisdiction.

Ironbark consid..

Ironbark Zinc Limited (ASX:IBG) major shareholder and non-executive director Danny Segman continues to support the companys base metals strategy with on-market share purchases.

On March 27 and 31 an entity in which Segman has a beneficial interest, Toronga Pty Ltd, acquired more than 1.875 million shares.

This took the number of shares held in the indirect interest to almost 82.417 million while another of Segmans indirect interests, Dulyne Pty Ltd, holds 67 million IBG shares.

Series of transactions


It is the latest in a series of on-market transactions by interests associated with Segman this year.

On March 24, 25 and 26 Toronga Pty Ltd acquired 3.54 million shares valued at more than $18,400 while on March 12 seven million shares were acquired worth more than $49,000.

Jewel in the crown


The company is confident that its Citronen Zinc-Lead Project in Greenland offers a rare scale and grade combination with a long mining life in a unique jurisdiction.

Ironbark considers Citronen the jewel in tRead More – Source

Continue Reading

Trending